Informations:
Erreur:
ID
18473
Description
Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00150657
Lien
https://clinicaltrials.gov/show/NCT00150657
Mots-clés
Versions (1)
- 07/11/2016 07/11/2016 -
Téléchargé le
7 novembre 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Non-Small Cell Lung Cancer NCT00150657
Eligibility Non-Small Cell Lung Cancer NCT00150657
- StudyEvent: Eligibility
Similar models
Eligibility Non-Small Cell Lung Cancer NCT00150657
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Non-Small Cell Lung Carcinoma | Non-small cell lung cancer recurrent post operative | Non-small cell lung cancer recurrent Post prior radiation therapy
Item
histologically or cytologically proven non-small cell lung cancer, newly diagnosed or recurrent after previous surgery and/or radiation therapy
boolean
C0007131 (UMLS CUI [1])
C0278517 (UMLS CUI [2,1])
C0241311 (UMLS CUI [2,2])
C0278517 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C0279134 (UMLS CUI [3,3])
C0278517 (UMLS CUI [2,1])
C0241311 (UMLS CUI [2,2])
C0278517 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C0279134 (UMLS CUI [3,3])
TNM clinical staging | Pleural Effusion, Malignant
Item
stage iv disease or stage iiib with a malignant pleural effusion
boolean
C3258246 (UMLS CUI [1])
C0080032 (UMLS CUI [2])
C0080032 (UMLS CUI [2])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
C1516986 (UMLS CUI [2])
ECOG performance status
Item
performance status 0 or 1 (ecog)
boolean
C1520224 (UMLS CUI [1])
Renal function | Liver function | Bone Marrow function
Item
adequate renal, hepatic, and bone marrow function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C0031843 (UMLS CUI [3,2])
C0232741 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C0031843 (UMLS CUI [3,2])
Operative Surgical Procedure Recovered | prior radiation therapy Recovered
Item
adequate recovery from previous surgery or radiotherapy
boolean
C0543467 (UMLS CUI [1,1])
C0521108 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C0521108 (UMLS CUI [2,2])
C0521108 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C0521108 (UMLS CUI [2,2])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
brain metastases
boolean
C0220650 (UMLS CUI [1])
Squamous cell carcinoma
Item
squamous (epidermoid) histology
boolean
C0007137 (UMLS CUI [1])
Hemoptysis
Item
hemoptysis
boolean
C0019079 (UMLS CUI [1])
airway disease Central
Item
central airway disease
boolean
C0699949 (UMLS CUI [1,1])
C0205099 (UMLS CUI [1,2])
C0205099 (UMLS CUI [1,2])
Pancoast Tumor
Item
pancoast tumors
boolean
C0549471 (UMLS CUI [1])
Prior Chemotherapy Malignant neoplasm of lung | Biological Response Modifier Therapy Malignant neoplasm of lung
Item
previous chemotherapy or biologic therapy for lung cancer
boolean
C1514457 (UMLS CUI [1,1])
C0242379 (UMLS CUI [1,2])
C0005527 (UMLS CUI [2,1])
C0242379 (UMLS CUI [2,2])
C0242379 (UMLS CUI [1,2])
C0005527 (UMLS CUI [2,1])
C0242379 (UMLS CUI [2,2])
Malignant Neoplasms | Skin carcinoma | Carcinoma in situ of uterine cervix
Item
prior malignancy within the previous 5 years except non-melanoma skin cancer or cervical cis
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
C0699893 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])